Overview

Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

This study is to investigate the effect of various modified low volume polyethylene glycol (PEG) 3350 and ascorbic acid/ascorbate (PEG+ASC)-based gut cleansing solutions on stool output in healthy subjects. In addition, the study is to assess and compare the safety and tolerance of the modified PEG+ASC formulations following oral administration with the safety profile of MOVIPREP®.

Phase:

Phase 1

Details

Lead Sponsor:

Norgine

Collaborator:

Pierrel Research Europe GmbH

Treatments:

Pharmaceutical Solutions
Polyethylene glycol 3350